(2026). Comparative Effectiveness of Upadacitinib vs. Other JAK Inhibitors in Patients With Rheumatoid Arthritis in a Global Real-World Setting. Rheumatology and Therapy.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Comparative Effectiveness of Upadacitinib Vs. Other JAK Inhibitors in Patients With Rheumatoid Arthritis in a Global Real-World Setting."
Rheumatology and Therapy 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Comparative Effectiveness of Upadacitinib Vs. Other JAK Inhibitors in Patients With Rheumatoid Arthritis in a Global Real-World Setting."
Rheumatology and Therapy, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.